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a b s t r a c t
Inducible nitric oxide synthase (iNOS) is a key enzyme in the macrophage inﬂammatory response, which is
the source of nitric oxide (NO) that is potently induced in response to proinﬂammatory stimuli. However, the
speciﬁc role of NO production, as distinct from iNOS induction, in macrophage inﬂammatory responses
remains unproven. We have generated a novel mouse model with conditional deletion of Gch1, encoding GTP
cyclohydrolase 1 (GTPCH), an essential enzyme in the biosynthesis of tetrahydrobiopterin (BH4) that is a
required cofactor for iNOS NO production. Mice with a ﬂoxed Gch1 allele (Gch1ﬂ/ﬂ) were crossed with Tie2cre
transgenic mice, causing Gch1 deletion in leukocytes (Gch1ﬂ/ﬂTie2cre). Macrophages from Gch1ﬂ/ﬂTie2cre mice
lacked GTPCH protein and de novo biopterin biosynthesis. When activated with LPS and IFNγ, macrophages
from Gch1ﬂ/ﬂTie2cre mice induced iNOS protein in a manner indistinguishable from wild-type controls, but
produced no detectable NO, as judged by L-citrulline production, EPR spin trapping of NO, and by nitrite
accumulation. Incubation of Gch1ﬂ/ﬂTie2cre macrophages with dihydroethidium revealed signiﬁcantly
increased production of superoxide in the presence of iNOS expression, and an iNOS-independent, BH4-
dependent increase in other ROS species. Normal BH4 levels, nitric oxide production, and cellular redox state
were restored by sepiapterin, a precursor of BH4 production by the salvage pathway, demonstrating that the
effects of BH4 deﬁciency were reversible. Gch1ﬂ/ﬂTie2cre macrophages showed only minor alterations in
cytokine production and normal cell migration, and minimal changes in basal gene expression. However,
gene expression analysis after iNOS induction identiﬁed 78 genes that were altered between wild-type and
Gch1ﬂ/ﬂTie2cre macrophages. Pathway analysis identiﬁed decreased NRF2 activation, with reduced induction
of archetypal NRF2 genes (gclm, prdx1, gsta3, nqo1, and catalase) in BH4-deﬁcient Gch1ﬂ/ﬂTie2cre macro-
phages. These ﬁndings identify BH4-dependent iNOS regulation and NO generation as speciﬁc requirements
for NRF2-dependent responses in macrophage inﬂammatory activation.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Macrophages are pivotal cells of the innate immune system, and
are a source of both pro- and anti-inﬂammatory cytokines, capable
of phagocytosing apoptic cells and have a potent antimicrobial arse-
nal [1]. Archetypal proinﬂammatory macrophages are activated by
interferon-γ and microbial products such as LPS, leading to produc-
tion of proinﬂammatory cytokines and high levels of nitric oxide
(NO), due to the induction of nitric oxide synthase. Generation of
NO by inducible nitric oxide synthase (iNOS, encoded by NOS2) is
implicated in critical functions such as microbial killing and
immune regulation [2]. However, inﬂammatory cells including
macrophages generate high levels of reactive oxygen speciﬁes
(ROS), that also play key roles in host defense and immunity.
Interactions between NO and ROS in cellular redox signaling are
important determinants of the inﬂammatory response, through
effects on redox-sensitive gene expression. For example, the activa-
tion of NRF2, leading to induction of antioxidant defense genes, is
stimulated by NO through nitrosylation of KEAP1 [3], but is also
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regulated by ROS [4] and other oxidatively modiﬁed molecules [5].
Indeed, incomplete understanding of the balance among NO, ROS,
and downstream redox effects may underlie the inconsistent effects
of “antioxidant” therapies [6].
The evidence that important redox functions for iNOS in macro-
phage activation are mediated by NO comes from analysis of mice
with genetic deletion of Nos2, which have altered systemic inﬂam-
matory responses to systemic infection, resulting in partial protection
from septic shock [2,7]. The effects of Nos2 deletion are presumed to
result from loss of NO generation by iNOS. However, deletion of Nos2
results in total absence of iNOS expression and activity, and this is not
synonymous with selective loss of NO generation, because the NOS
enzymes are complex oxido-reductases with the potential to produce
ROS as well as, or instead of, NO [8]. Speciﬁcally, the NOS enzymes
require the pterin cofactor tetrahydrobiopterin (BH4) for NO produc-
tion [9]. BH4 participates in electron transfer during the two-step
oxidation of L-arginine to L-citrulline via an N-hydroxyarginine
intermediate. In the absence of BH4, NOS enzymes are unable to
generate NO by oxidation of L-arginine, and become “uncoupled,”
whereby reduction of molecular oxygen, driven by electron ﬂow from
the NOS reductase domain, can generate superoxide or other ROS.
Uncoupled NOS appears to play important roles in pathophysiologic
regulation of ROS in, for example, cardiovascular disease [10]. Inhibi-
tion of iNOS function by BH4 structural analogues in vitro can block
iNOS-mediated NO production, and may have effects on the systemic
response to septic shock [11,12]. However, the physiological require-
ment for BH4 in iNOS function is unclear. In particular, it is not known
whether the role of BH4 in inﬂammatory cell function alters the
response to cytokine stimulation, or the downstream consequences of
iNOS signaling mediated by either NO or ROS. These questions are
important because understanding the mechanisms regulating iNOS
signaling in inﬂammation, via either NO or ROS, is critical in designing
rational therapeutic approaches to target iNOS function in conditions
such as host defense, immune function, and sepsis.
We hypothesized that deletion of Gch1 in macrophages would
prevent NO production by iNOS and allow dissection of putative
roles for iNOS-derived NO, vs other functions of iNOS, such as ROS
production, that are not dependent on NO production. We gener-
ated a novel mouse model with targeted deletion of Gch1, the
enzyme required for BH4 synthesis, in order to prevent NO
production by iNOS, but maintain ROS production. We investi-




All animal studies were conducted with ethical approval from the
Local Ethical Review Committee and in accordance with the UK Home
Ofﬁce regulations (Guidance on the Operation of Animals, Scientiﬁc
Procedures Act, 1986). Mice were housed in ventilated cages with a
12-h light/dark cycle and controlled temperature (20–22 1C), and fed
normal chow and water ad libitum.
Generation of Gch1 knockout mice
A novel mouse model of BH4 deﬁciency was created by condi-
tional deletion of Gch1, that encodes GTP cyclohydrolase I the rate
limiting enzyme in BH4 biosynthesis [13]. Exons 2 and 3 of Gch1,
encoding for the active site of GTPCH, were ﬂanked by loxP sites in a
targeting construct that was used to produce Gch1ﬂ/ﬂ mice following
homologous recombination in ES cells (Fig. 1A). These mice were
crossed with Tie2cre transgenic mice to produce Gch1ﬂ/ﬂTie2cre mice
where Gch1 is deleted in endothelial and bone marrow-derived cells
[14–16]. The Tie2cre transgene is active in the female germline; hence
only male animals are used to establish breeding pairs to maintain
conditional expression. Mice were genotyped using primers targeted
against the ﬂoxed Gch1 allele, and in a separate reaction for the
presence of the cre sequence. Experiments were performed using
bone marrow isolated from age and sex matched littermate animals.
Animals were genotyped using DNA prepared from ear notches
using the following PCR primers: Cre, 50 GCATAACCAGTGAAACAG-
CATTGCTG 30 and 50 GGACATGTTCAGGGATCGCCAGGCG 30; Gch1 ﬂo-
xed allele, 50GTCCTTGGTCTCAGTAAACTTGCCAGG30 and 50GCCCAGC-
CAAGGATAGATGCAG30.
Isolation of murine bone marrow-derived macrophages
Bone marrow was obtained by ﬂushing the femur and tibia of
adult mice with PBS. A single cell suspension was prepared by
passing the bone marrow through a 70 mm cell strainer. Cells were
then cultured in 10 cm nontissue culture treated dishes for 7 days
in DMEM:F12 (Invitrogen) supplemented with 100 U/ml penicillin
and 100 ng/ml streptomycin (Sigma), 10% (v/v) fetal bovine serum
(PAA Laboratories), 5 mM L-glutamine (Sigma), and 10–15% (v/v)
L929 conditioned medium at 37 1C and 5% CO2. The differentiation
of the cells was conﬁrmed using ﬂow cytometry using a CyAn ADP
(Beckton Coulter) for data acquisition and Flow Jo (TreeStar Inc.)
for analysis. Macrophages were deﬁned as being CD11b (PerCP
conjugated) and F4:80 (APC conjugated, both Biolegend) positive
cells, as judged against isotype controls conjugated with the same
ﬂuorochromes (Biolegend).
Stimulation of bone marrow-derived macrophages
Following differentiation cells were harvested and plated into 6- or
12-well plates containing serum-free media (Optimem supplemented
with 100 U/ml penicillin and 100 ng/ml streptomycin and 0.2% (w/v)
low-endotoxin bovine serum albumin (Sigma)). Cells were stimulated
with 10 ng/ml IFNγ (Peprotech EC) and 100 ng/ml LPS (Sigma) for
24 h, parallel wells were left unstimulated. After 24 h cell pellets, and
cell culture supernatants were collected, or the cells subjected to
biochemical analysis.
Genomic DNA production and excision PCR
Genomic DNA for detection of the excised allele was produ-
ced using the Qiamp kit (Qiagen). The ﬂoxed and excised all-
ele were detected using the following primers: 50GTCCTTGGTC
TCAGTAAACTTGCCAGG30, 50GCCCAGCCAAGGATAGATGCAG30, and
50GCTCATCCCCCACACTTGTCTT30. The ﬂoxed allele yields a 1030-
bp product and the excised allele a product of 1300 bp.
Determination of tetrahydrobiopterin levels
BH4 and oxidized biopterins (BH2 and biopterin) were deter-
mined by high-performance liquid chromatography (HPLC) fol-
lowed by electrochemical and ﬂuorescent detection, respectively,
following an established protocol [17]. Cell pellets were freeze–
thawed in ice-cold resuspension buffer (50 mM phosphate-buffered
saline, 1 mM dithioerythriol, 1 mM EDTA, pH 7.4). After centrifuga-
tion at 13,200 rpm for 10 min at 4 1C, supernatant was removed and
ice-cold acid precipitation buffer (1 M phosphoric acid, 2 M tri-
chloroacetic acid, 1 mM dithioerythritol) was added. Following
centrifugation at 13,200 rpm for 10 min at 4 1C, the supernatant
was removed and injected onto the HPLC system. Quantiﬁcation of
BH4 and oxidized biopterins was obtained by comparison with
external standards and normalized to protein concentration, deter-
mined by the BCA protein assay (Pierce).
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Nitrite determination
Nitrite accumulation was measured in samples of cell culture
medium using the Griess assay with colorimetric detection in 96-well
plates, as described [18].
Determination of NO production by electron paramagnetic resonance
Electron paramagnetic resonance (EPR) spectroscopy was used to
quantify aortic NO production, as described previously [19]. Brieﬂy,
cultured macrophages were incubated with colloid iron (II) diethyl-
dithiocarbamate [Fe(DETC)2] (285 mmol/L) at 37 1C for 90 min. After
incubation, cells were harvested and snap-frozen in a column of
Krebs-Hepes buffer in liquid nitrogen, and EPR spectra were obtained
using an X-band EPR spectrometer (Miniscope MS 200; Magnettech).
Signals were quantiﬁed by measuring the total amplitude, after
correction of baseline, and after subtracting background signals from
incubation with colloid Fe(DETC)2 alone.
Western blot analysis
Western blot analysis was performed using antibodies against
murine GTPCH (a gift from S. Gross), iNOS (BD Pharmigen), and
β-tubulin (Abcam), using standard protocols. iNOS monomer and
dimer analysis was conducted on nonreduced samples with all
elements of the experiment conducted at 4 1C.
Analysis of NO synthesis by iNOS
NO synthesis by iNOS was assessed by conversion of [14C]
L-arginine to citrulline, in the presence and absence of N-methyl-L-
arginine, as described previously [20]. Brieﬂy, macrophages were
incubated for 2 h at 37 1C in 200 μl Krebs-Hepes buffer containing
[14C]arginine (2 μl of 50 μCi/mL, Hartmann Radiochemicals). Samples
were run on a SCX 300 cation-exchange HPLC column (Sigma) with
online scintillation detection. Background signals were corrected from
samples incubated with [14C]arginine alone, without cells.
Quantiﬁcation of intracellular superoxide production by
dihydroethidine HPLC
Superoxide production was quantiﬁed by measuring produc-
tion of 2-hydroxyethidium from dihydroethidium using HPLC
[21,22]. Cultured macrophages were pretreated with or with-
out 2 mM L-NAME (Sigma), 100 U/ml PEG-SOD (Sigma), or 5 mM
Sepiapterin (Schircks) prior to addition 25 mM DHE (Invitrogen) for
30 min before being harvested for separation of DHE using a
gradient HPLC system (Jasco, UK) with an ODS3 reverse phase
column (250 mm, 4.5 mm, Hichrom UK) and quantiﬁed using a
ﬂuorescence detector set at 510 nm (excitation) and 595 nm
(emission). To assess oxidative burst, cells were stimulated with
2 μM PMA (Sigma) directly after addition of DHE to the cell
culture media.
Cytokine protein array
Media from stimulated and unstimulated macrophages were
harvested after 24 h and any cell debris was removed by centri-
fugation. The resulting supernatants were applied to Proteome
Proﬁler Arrays (R&D Systems) as a batch. The arrays were devel-
oped according to the manufacturer's instructions. The intensity of
the cytokine signals was quantiﬁed from high resolution scans
using ImageJ software.
xCELLigence real-time chemotaxis assay
Bone marrow-derived macrophages were de-adhered following
differentiation using PBS/5 mM EDTA and then subjected to chemo-
taxis assays in CIM 16-well plates using an xCELLigence RTCA-DP
instrument as described previously [23]. Brieﬂy, agonists were loaded
into the lower chamber of the CIM 16 plate and the upper chamber
Fig. 1. (A) Schematic showing the targeting of the mouse Gch1 locus indicating the position of the loxP sites ﬂanking exons 2 and 3, which encode the active site of the GTPCH
enzyme. Arrows indicate the position of primers that produce the 1030-bp product from the ﬂoxed allele (solid green arrows) and the 1392-bp product following excision of the
ﬂoxed DNA (solid and open green arrows). (B) Flow cytometry dot plots show expression of CD11b and F4/80 on the cell surface of wild-type (WT) and Gch1ﬂ/ﬂTie2cre bone marrow-
derived macrophages, indicating similar differentiation in both genotypes after 7 days of culture of bone marrow cells in macrophage differentiation media. (C) Genomic PCR shows
the presence of the ﬂoxed allele in WTcells and the near complete excision of the ﬂoxed allele in Gch1ﬂ/ﬂTie2cre bone marrow-derived macrophages. (D) Measurement of BH4 in the
cells shows a near complete loss of BH4 in Gch1ﬂ/ﬂTie2cre cells. (n¼3, Po0.05).
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was attached. The electrode-embedded membrane was equilibrated
with prewarmed buffer for 30 min prior to addition of 5104 cells.
Migration was assessed every 5 s for 4 h in total. Data were normal-
ized to wells that received media alone and analysis of area
maximum–minimum signal was carried out with RCTA Software
version 1.2.1. Data are displayed as cell index relative to media alone
control.
Gene array analysis
Total RNA was extracted from each sample using a mirVana kit
(Ambion). The RNA quantity and quality were determined using
the Agilent BioAnalyzer 2100 (Agilent Technologies). Gene expres-
sion data were obtained by hybridizing a total of 24 mouse sam-
ples from two experimental groups, over 4 time points: WT and
Gch1ﬂ/ﬂTie2cre at 0, 2, 8, or 24 h post stimulation (n¼3 per group)
to Illumina MouseWG-6(V2) BeadChips. Chips were scanned with
Illumina BeadArray Reader; GenomeStudio V2010.1 (Illumina Inc)
was used for data extraction. Data underwent variance stabiliza-
tion and normalization (VSN) algorithm using Limma [24]. Nor-
malized data were imported to Bioconductor (R version 2.14)
(Biobase) and comparison by genotype was performed for each
time point to identify signiﬁcantly differentially expressed genes
passing a false discovery rate of o0.05 [25]. The lists of differen-
tially expressed genes were then subject to IPA pathway analysis
(Ingenuity Systems, http://www.ingenuity.com).
Quantitative real-time RT-PCR
RNA, prepared as described above, were reverse-transcribed
using Superscript II (Life Technologies) and random hexamer
primers (Invitrogen) according to standard protocols. A 50 ng
RNA equivalent cDNA was used to perform real-time PCR using
predesigned TaqMan gene expression assays (Life Technologies)
using a BioRad CFX1000. Gene expression data were normalized to
β-actin expression.
Statistical analysis
Data are expressed asmean 7 SEM. Comparisons betweenWTand
GCH1ﬂ/ﬂTie2cre were made by the unpaired Student t test. Experiments
testing multiple doses between genotypes were compared by two-way
ANOVA, with post tests applied to test for signiﬁcance between
genotypes or treatments as outlined in the ﬁgure legends. A P value
of less than 0.05 was considered statistically signiﬁcant.
Results
Cell-targeted Gch1 deletion reveals a requirement for BH4
biosynthesis in macrophage iNOS function
We generated matched litters of Gch1ﬂ/ﬂTie2cre and Gch1ﬂ/ﬂ mice
(hereafter referred to as wild-type) by crossing male Gch1ﬂ/ﬂTie2cre
and female Gch1ﬂ/ﬂmice (Fig. 1A). Bone marrow-derived macrophages
were cultured from primary bone marrow, conﬁrmed by identiﬁca-
tion of the cells as CD11bþ F4/80þ by ﬂow cytometry (Fig. 1B).
Genomic PCR of macrophage DNA demonstrated near total excision of
the ﬂoxed Gch1 allele in Gch1ﬂ/ﬂTie2cre mice (Fig. 1C). Deletion of
Gch1 resulted in a near complete loss of cellular BH4 in bone marrow-
derived macrophages from Gch1ﬂ/ﬂTie2cre mice compared to wild-
type controls (Po0.01, Fig. 1D).
We next tested the effect of cytokine stimulation on iNOS exp-
ression and BH4 synthesis in bone marrow-derived macrophages.
Stimulation of macrophages with LPS and interferon-γ resulted in
marked induction of iNOS protein levels, identiﬁed by Western blot,
from undetectable levels at baseline, that was not different in
Gch1ﬂ/ﬂTie2cre compared with wild-type mice (Fig. 2A). In wild-
type mice, GTPCH protein was present at baseline and was upregu-
lated in response to LPS and interferon-γ stimulation. However, in
Gch1ﬂ/ﬂTie2cre mice, no GTPCH protein was detectable either at
baseline or after LPS and interferon-γ stimulation. These changes in
GTPCH protein were paralleled by quantiﬁcation of Gch1 mRNA by
RT-PCR, showing an upregulation of Gch1 expression in wild-type
cells after LPS and interferon-γ stimulation, but undetectable Gch1
expression in either basal or stimulated Gch1ﬂ/ﬂTie2cre macrophages
(Fig. 2B). Strikingly, levels of BH4, and the oxidized species dihydro-
biopterin (BH2) and biopterin (B), remained virtually undetectable in
stimulated Gch1ﬂ/ﬂTie2cre macrophages, despite a signiﬁcant upregu-
lation of biopterins in wild-type macrophages (Fig. 2C). To determine
whether the biopterin salvage pathway was intact we stimulated BH4
production by supplementation with sepiapterin, which augments
BH4 levels via the salvage pathway, independent of de novo BH4
biosynthesis by GTPCH. Sepiapterin supplementation signiﬁcantly
increased intracellular BH4 in the Gch1ﬂ/ﬂTie2cre cells, restoring them
to wild-type levels (Fig.2D). This shows that iNOS enzymatic activity
is otherwise unaffected and the effects seen are due to a lack of
cofactor availability in the Gch1ﬂ/ﬂTie2cre cells.
We next determined the effects of macrophage Gch1 deletion and
BH4 deﬁciency on NO generation, using three different methods. First,
we measured authentic NO generation from macrophages using EPR
detection of NO using the spin-trap colloid Fe(DETC)2. The character-
istic NO-Fe(DETC) 2 EPR triplet was readily demonstrated in activated
wild-type macrophages, but was not detectable in Gch1ﬂ/ﬂTie2cre
macrophages (Fig. 3A). A similar result was observed using radiola-
beled L-arginine to L-citrulline conversion using HPLC with on-line
scintillation detection. No L-citrulline production was detected in
Gch1ﬂ/ﬂTie2cre macrophages, compared with more than 15% conver-
sion of L-arginine to L-citrulline in activated wild-type cells (Fig. 3B).
Finally, we measured nitrite production by macrophages using the
Greiss assay. Wild-type macrophages accumulated high levels of
nitrite (>50 mM) in culture medium 24 h after stimulation with LPS
and interferon-γ, whereas nitrite was barely detectable in medium
from Gch1ﬂ/ﬂTie2cre macrophages (Fig. 3C). To test the speciﬁcity of
the nitric oxide production the cells were treated with either the
nonselective NOS inhibitor L-NAME or the iNOS selective inhibitor
1400W (Fig. 3D). The accumulation of nitrite was signiﬁcantly
reduced in wild-type cells by both inhibitors. To conﬁrm whether
the lack of nitric oxide production by the Gch1ﬂ/ﬂTie2cre cells was
purely due to a lack of BH4, Gch1ﬂ/ﬂTie2cre macrophages were
activated in the presence of sepiapterin, to restore BH4 levels by the
salvage pathway, which restored nitrite levels to wild-type levels
(Fig. 3D). To further assess alterations to iNOS activity in the absence of
BH4 we performed Western blotting of the native protein to deter-
mine any contribution of BH4 to the dimerization of iNOS. We found a
decrease in dimeric iNOS in the Gch1ﬂ/ﬂTie2cre macrophages. In both
wild-type and Gch1ﬂ/ﬂTie2cre cells a prominent signal for monomeric
iNOS was detected (Fig. 3E). A parallel aliquot of the lysate was
prepared under normal reducing conditions to conﬁrm that the total
iNOS expression was unchanged between genotypes. Taken toge-
ther, these observations demonstrate that macrophage Gch1 deletion
renders iNOS inactive for NO generation that is mediated by BH4
deﬁciency.
To investigate the effects of Gch1 deletion and BH4 deﬁciency on
macrophage ROS production, we next measured O2 and other ROS
in bone marrow-derived macrophages by quantiﬁcation of 2-
hydroxyethidium (2-HE) and ethidium (E) production from dihy-
droethidine, using HPLC. The production of 2-HE was signiﬁcan-
tly elevated in macrophages from Gch1ﬂ/ﬂTie2cre mice compared
with wild-type cells, but only in the LPS and interferon-γ-activated
macrophages (Fig. 4A–C). The speciﬁcity of the production of 2-HE
was conﬁrmed by analyzing the PEG-SOD-inhibitable signal. While a
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clear production of superoxide is detectable in both the stimulated
and the unstimulated macrophages, this production is not signiﬁ-
cantly altered by coincubation with L-NAME. In the case of the
ethidium signal, the production is signiﬁcantly increased in the
Gch1ﬂ/ﬂTie2cre macrophages under both unstimulated and activated
conditions (Fig. 4D and E). This overproduction of ethidium by the
Gch1ﬂ/ﬂTie2cre cells was particularly striking, being visible as an
alteration in the color of the cell pellets following dihydroethidium
incubation (Fig. 4C). This signal was not inhibited by coincubation
with PEG-SOD, nor with the NOS inhibitor, L-NAME (2 mM), which
produced little effect. These data indicate a role for BH4 in regulating
both superoxide production in the presence of iNOS expression and
in the production of other ROS species that are independent of NOS
expression. Having observed signiﬁcant alterations in the production
of multiple ROS species in the BH4-deﬁcient cells, we next assessed
how the cells would react to a potent superoxide signal, induction of
the oxidative burst by PMA. The magnitude of the superoxide signal
was not signiﬁcantly different between genotypes (Fig. 4F). In
addition, the production of this large superoxide signal did not alter
the detected ethidium signal (Fig. 4G), indicating that the ethidium
signal is independent of superoxide production by the cells. To
further probe the origin of the elevated ethidium signal, cells were
subject to either rescue of intracellular BH4 levels, by addition of
sepiapterin, or treatment with a nonspeciﬁc antioxidant, Vitamin C
(Fig. 4H). In both cases the ethidium signal was signiﬁcantly
decreased in the Gch1ﬂ/ﬂTie2cre macrophages, indicating that the
increased ethidium signal is the result of intracellular oxidants.
These experiments indicate that ROS levels within the cells are
altered in a BH4-dependent manner both in the presence and in the
absence of iNOS protein expression.
Macrophage BH4 deﬁciency and loss of NO lead to altered
inﬂammatory responses and gene expression
Next we investigated the requirement for macrophage BH4
synthesis in the inﬂammatory response to LPS and interferon-
γstimulation. A systematic quantiﬁcation of the secretion of a
range of cytokines and chemokines, using a protein array, revealed
that the production of mediators including MIP-2, MIP1α , MIG,
MCP-5, IL-27, IL-10, IL-6, sICAM-1, G-CS,F and TIMP-1 was not
signiﬁcantly different between wild-type and Gch1ﬂ/ﬂTie2cre
macrophages (Fig. 5A and B). We also measured cytokines induced
by proinﬂammatory stimulation in macrophage culture media by
ELISA, revealing a small but statistically signiﬁcant reduction in
Fig. 2. (A) Western blotting shows a lack of expression of GTPCH protein in Gch1ﬂ/ﬂTie2cre macrophages, compared to wild-type (WT) macrophages that show increased
expression following activation with LPS (100 ng/ml) and IFNγ (10 ng/ml) for 24 h. Both genotypes of cells showed similar induction of iNOS protein following activation.
Equal protein loading was demonstrated by detection of β-tubulin, n¼3 independent cell preparations. (B) Gene expression analysis of cells 24 h after stimulation showed a
signiﬁcant induction of Gch1 RNA; in contrast Gch1 RNA was undetectable in Gch1ﬂ/ﬂTie2cre cells (n¼3, Po0.05). (C) BH4 and BH2 were upregulated in wild-type
macrophages following activation. All forms of biopterin were signiﬁcantly reduced to near undetectable levels in Gch1ﬂ/ﬂTie2cre cells. (D) Treatment of macrophages with
5 μM Sepiapterin for 24 h signiﬁcantly increased BH4 content in Gch1ﬂ/ﬂTie2cre cells, to levels that were not signiﬁcantly different from wild-type cells (n¼4, Po0.05).
*Po0.05, difference by genotype; § Po0.05, difference from control. Two-way ANOVA.
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Fig. 3. (A) Representative EPR spectra from wild-type (WT) and Gch1ﬂ/ﬂTie2cre macrophages following activation with LPS (100 ng/ml) and IFNγ (10 ng/ml). The
characteristic triple-peaked trace associated with NO-Fe(DETC)2 signal was readily detectable in the wild-type cells, but absent in the Gch1ﬂ/ﬂTie2cre cells. Quantiﬁcation of
the EPR signal indicated nitric oxide production only by activated wild-type cells (n¼3). (B) Representative HPLC traces showing arginine to citrulline conversion by wild-
type macrophages, which was absent in Gch1ﬂ/ﬂTie2cre cells. Quantiﬁcation of the NMA-inhibitable arginine to citrulline conversion indicated signiﬁcantly reduced NOS
enzyme activity in the Gch1ﬂ/ﬂTie2cre macrophages. (C) Nitrite accumulation in the cell culture media over 24 h of cell stimulation was measured using the Griess assay. No
nitrite production was detected in the absence of stimulation with LPS/IFNγ, but after stimulation was readily detected in wild-type supernatants, but was virtually
undetectable levels in the Gch1ﬂ/ﬂTie2cre cells (n¼6, Po0.05). (D) The production of nitrite was signiﬁcantly reduced by treatment with L-NAME (2 mM) over the 24 h
stimulation in wild-type cells, and was completely blocked by incubation with iNOS inhibitor 1400W (10 nM). Production of nitrite by Gch1ﬂ/ﬂTie2cre cells was signiﬁcantly
enhanced by coincubation of the cells with 5 μM sepiapterin during the 24 h cell stimulation. (E) Macrophage lysates from activated cells were run under nonreducing
conditions to assess iNOS monomer and dimer formation. Total iNOS and GTPCH content was assessed from duplicate reduced lysate samples under standard blotting
conditions. The identity of the bands obtained were conﬁrmed using control lysates from wild-type nonactivated (u/t BMDM) and activated macrophage lysates (LPS/IFNγ
BMDM) and activated iNOS/ lysates (iNOS / BMDM).
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TNFα and IL-6 secretion by Gch1ﬂ/ﬂTie2cre macrophages (Fig. 5C
and D). More surprisingly, secretion of PGE2 was not affected, as
reduced PGE2 production is reported by iNOS / macrophages
(Fig. 5E) [26]. To further investigate the effects of Gch1 deletion on
macrophage function, chemotaxis assays were performed to assess
cell motility. The BMDMs showed signiﬁcant migration in
response to both classical chemokines (CCL5) and chemoattrac-
tants (C5a) (Fig. 5F). However, there was no signiﬁcant difference
in cell migration between wild-type and Gch1ﬂ/ﬂTie2cre macro-
phages (Fig. 5F). Taken together, these data reveal a selective
impact of BH4 deﬁciency on cell redox status, with alterations in
both nitric oxide and ROS production, in the absence of large
changes in other cell functions.
We next investigated how the loss of NO production and
increased ROS production induced by loss of BH4 would alter
gene expression in macrophages after LPS and interferon-γ sti-
mulation, using gene array analysis of macrophage mRNA (Fig. 6A).
Macrophages from wild-type and Gch1ﬂ/ﬂTie2cre mice were
harvested at baseline or 2, 8, or 24 h after stimulation with LPS
and interferon-γ. The change in gene expression in response to
inﬂammatory stimulation was similar between genotypes, reﬂect-
ing the broadly similar levels of cytokine and chemokine secretion.
Pairwise comparison of gene expression between wild-type and
Gch1ﬂ/ﬂTie2cre macrophages at baseline revealed the expected
decrease in Gch1 gene expression and in addition a signiﬁcant
reduction in arsenite-3-methlytransferase (As3mt) expression
(Supplementary Table 1). This minimal Gch1-dependent change
in gene expression was also seen at 2 h post stimulation. At 8 h
after stimulation a signiﬁcant decrease in Cxcl5 expression was
seen in addition to the changes in As3mt expression (Sup-
plementary Table 1). However, 24 h after stimulation 78 genes
were altered in Gch1ﬂ/ﬂTie2cre cells (Fig. 6A and Supplementary
Table 1). Validation of selected genes signiﬁcantly altered in
Gch1ﬂ/ﬂTie2cre cells, by RT-PCR, conﬁrmed signiﬁcant upregula-
tion of genes in wild-type macrophages that were strikingly
reduced or absent in Gch1ﬂ/ﬂTie2cre macrophages (Fig. 6B). This
Fig. 4. Following activation with LPS (100 ng/ml) and IFNγ (10 ng/ml) cells or control cells were pretreated with or without PEG-SOD (100 U/ml) for 30 min prior to incubation
with dihydroethidium for 30 min. The production of 2-hydroxyethidium and ethidium was quantiﬁed using HPLC with ﬂuorescence detection. The speciﬁcity of the
2-hydroxyethidium signal to superoxide was conﬁrmed by quantiﬁcation of the PEG-SOD-inhibitable signal. (A) In the absence of cell stimulation no signiﬁcant difference in
superoxide was detected between wild-type (WT) and Gch1ﬂ/ﬂTie2cre cells. (B) Following activation Gch1ﬂ/ﬂTie2cre cells produced signiﬁcantly more superoxide than wild-type
cells. The superoxide signals detected were not inhibitable by L-NAME (2 mM). (C) Representative HPLC trace showing the alterations in dihydroethidium oxidation in wild-type
and Gch1ﬂ/ﬂTie2cre cells. Notably Gch1ﬂ/ﬂTie2cre cell pellets were bright red in color (ethidium) following the experiment. (D) Quantiﬁcation of the ethidium signal indicated a
signiﬁcant increase in Gch1ﬂ/ﬂTie2cre cells under both basal and stimulated conditions (E). The elevated ethidium signal was not signiﬁcantly inhibited by PEG-SOD (100 U/ml) or
L-NAME (2 mM). (F) Superoxide burst was induced by treatment with 2 μM PMA in the presence of dihydroethidium. The PEG-SOD-inhibitable production of superoxide was not
signiﬁcantly difference between genotypes. (G) Induction of the superoxide burst did not alter the elevated production of ethidium by the Gch1ﬂ/ﬂTie2cre cells. (H) Pretreatment of
the cells with Sepiapterin for 24 h or vitamin C for 30 min signiﬁcantly reduced the elevated ethidium signal detected in the Gch1ﬂ/ﬂTie2cre cells (n¼3–6 per group, Po0.05).
*Po0.05, difference by genotype; § Po0.05, difference from control. Two-way ANOVA.
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validation was performed both with the RNA samples used for the
gene array and with further RNA samples from additional biolo-
gical replicates.
The gene array revealed changes in genes related to the BH4-
dependent enzyme pathways of catecholamine synthesis, α-1-adre-
noceptor, and the AGMO-dependent ether lipid metabolism pathway,
platelet activating factor acetyl hydrolase (Pafah) (Supplementary
Table 1). Ingenuity Pathway analysis of the genes signiﬁcantly altered
at 24 h revealed a signiﬁcant modulation of the NRF2 pathway,
predicting a decrease in upstream NRF2 activity in the Gch1ﬂ/ﬂTie2cre
cells. Pathway analysis predicts decreased activation of NRF2 following
reduced expression of 6 out 8 key NRF2 targets in Gch1
ﬂ/ﬂ
Tie2cre cells
(Po0.05). The identiﬁcation of altered NRF2 target gene expression
was conﬁrmed by RT-PCR of analysis of established NRF2-dependent
genes (Gclm, Prdx1, Gsta3, Nqo1, and Catalase) showing an apparent
decrease in NRF2 activity in Gch1ﬂ/ﬂTie2cre macrophages (Fig. 6C).
Fig. 5. (A) Supernatants were collected from wild-type (WT) and Gch1ﬂ/ﬂTie2cre macrophages 24 h after stimulation with LPS (100 ng/ml) and IFNγ (10 ng/ml). Proteome
Proﬁler arrays, cytokine detection antibodies prespotted onto nitrocellulose ﬁlters in duplicate, were used to proﬁle cytokine secretion. The intensity of the cytokine signal
was quantiﬁed using densitometry for n¼4 biological replicates per genotype. (B) Representative cytokine arrays show no signiﬁcant differences between genotypes.
(C) Detection of PGE2 by enzyme immunoassay indicated no alteration in production by Gch1ﬂ/ﬂTie2cre cells. (D) Detection of TNFα and IL-6 (E) by ELISA indicated induction
of both cytokines by stimulation, with a small but signiﬁcant reduction in cytokine production by the Gch1ﬂ/ﬂTie2cre cells (cytokine detection n¼6 per genotype, Po0.05).
(E) Representative trace from the RTCA-DP software showing macrophage migration toward chemoattractant or buffer control. Quantiﬁcation of the response in the
xCELLigence assay showed that migration toward either CCL5 or C5a was not signiﬁcantly altered in Gch1ﬂ/ﬂTie2cre macrophages (n¼3 per genotype).
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Discussion
We have created a novel mouse model of Gch1 deletion in order to
test the speciﬁc requirements for BH4 in macrophage redox biology.
This novel mouse model reveals several new and important ﬁndings.
First, Gch1 deletion leads to near total macrophage BH4 deﬁciency,
which in turn leads to loss of iNOS-derived NO bioactivity. Second,
macrophage ROS production is increased by BH4 deﬁciency and is in
part iNOS mediated but is also observed in the absence of iNOS
expression. Third, analysis of macrophage gene expression reveals
speciﬁc alteration to a set of 78 genes following iNOS induction that
are dependent on BH4 levels. In particular, NRF2-dependent genes
showed reduced induction in Gch1ﬂ/ﬂTie2cre macrophages. Taken
together, these data reveal a requirement for BH4 in regulating
cellular redox state, through direct effects on iNOS-mediated NO,
ROS production and through downstream alterations in NRF2-
dependent gene expression.
The identiﬁcation of these speciﬁc requirements for Gch1, BH4, and
iNOS-dependent NO generation has important implications for under-
standing the regulation of macrophage activation and gene expression.
Fig. 6. (A) Heat map showing gene expression of genes signiﬁcantly regulated by 41.5-fold passing a fdr Po0.05 across a time course of gene expression. All genes
signiﬁcantly regulated by genotype in at least one time point are shown, ranked by fold difference between wild-type (WT) and Gch1ﬂ/ﬂTie2cre macrophages at 24 h (n¼3
per genotype per time point, paired data). Data shown are the average normalized log2 expression value for each gene normalized to the expression across all samples. Green
represents a positive change and red represents a negative change. (B) Conﬁrmation of gene array result by quantitative RT-PCR of RNA from cells with or without
stimulation with LPS (100 ng/ml) and IFNγ (10 ng/ml) for 24 h. (C) Conﬁrmation of decreased expression of NRF2 target genes 24 h following stimulation as above. (RT-PCR
studies n¼6 per genotype, two-way ANOVA *Po0.05, ** Po0.01, ***Po0.001 for difference by genotype).
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NO has been reported to have multiple divergent effects on cytokine
production, with both induction and inhibition of cytokine production
reported following treatment with NO donors [27]. However, our data
now show that macrophage cytokine production following inﬂamma-
tory stimulation is largely preserved even when iNOS-dependent
NO production is absent. Conversely, the speciﬁc reduction in NRF2-
dependent gene expression in BH4-deﬁcient macrophages strongly
supports a requirement for NO in activation of NRF2 by nitrosylation of
Keap1 [28], even though NRF2 can also be induced by ROS [4]. In this
regard, the observations in Gch1-deﬁcient macrophages are concor-
dant with those from Nos2 / mice that show decreased activation of
NRF2 in response to proinﬂammatory stimuli [29]. However, given the
large alterations in NO-ROS balance in the Gch1ﬂ/ﬂTie2cre macro-
phages we cannot fully rule out ROS-mediated alterations in NRF2
activation. In contrast, gene expression analysis in BH4-deﬁcient
macrophages following activation identiﬁes a novel subset of genes
that are dependent on iNOS, but not on NO production, thus
implicating other iNOS signaling roles such as ROS production.
Dissecting out the relative roles of iNOS-derived NO vs other iNOS
effects cannot be determined using the Nos2 / mouse, where all
iNOS effects will be absent. For example, Nos2 / macrophages are
reported to have a striking lack of PGE2 induction, hypothesized to be
via reduced S-nitrosylation of COX2. However, we observed no
signiﬁcant alteration in PGE2 levels in BH4-deﬁcient macrophages,
indicating that other roles for iNOS may mediate this activation of
COX2 [26].
The potential importance of BH4 in regulating ROS-mediated
effects in macrophages is supported by striking increases in super-
oxide production in BH4-deﬁcient activated macrophages that paral-
lels loss of NO generation by iNOS. This novel system allows for the
ﬁrst time a comparison between NO-mediated and ROS-mediated
effects of iNOS induction in macrophages. While the production of
superoxide by iNOS has been reported, the precise control of ROS
production by BH4 is more controversial. Some studies have shown
that iNOS becomes uncoupled by a lack of BH4 and that superoxide-
induced oxidative loss of BH4 causes ROS formation [30]. Restriction
of arginine availability is also reported to cause increased ROS
production by iNOS [31], resulting in peroxynitrite formation [32].
Recent studies have shown that the ferrous inducible oxygenase
domain of iNOS remains monomeric in the absence of BH4 and
produces superoxide [33]. However, isolated protein systems have
shown that the formation of the iNOS dimer, which is required for NO
production, is more BH4 dependent than other NOS isoforms [8]. In
whole cell and body systems iNOS uncoupling is observed, with
reduced BH4 causing increased iNOS uncoupling in T-cells and in
renal allografts associated with a BH4-inhibitable superoxide produc-
tion [34,35]. In addition to enhanced superoxide production, which
may be a result of iNOS uncoupling, the more striking effect of loss of
BH4 on cellular redox state is the enhanced ethidium signal detected.
This signal is independent of NOS expression, indicating for the ﬁrst
time that the physiological level of BH4 has a role in controlling
cellular redox state. The source of this ROS signal is unclear; it seems
unlikely to be via NOX2 since induction of the phagocytic oxidative
burst by PMA is unaltered between genotypes. These data indicate
that basal ROS production from other sources may be elevated, or that
BH4 forms part of the physiological intracellular redox buffering
capacity of the cell.
The ability of macrophages to produce high levels of ROS and RNS
requires macrophages themselves to induce cell processes that allow
protection from the local aggressive local environment. This protec-
tion is mediated in part through induction of redox-sensitive
transcription factors, such as HIF and NRF2 [29]. In addition to the
core group of NRF2-regulated genes that show altered regulation in
the Gch1ﬂ/ﬂTie2cre mice, other gene expression changes reﬂect
changes previously associated with NO production. For example,
Slc40a1 (Ferroportin) gene expression has been reported to be
induced by nitric oxide, with a failure of induction in iNOS / mice
[36]. However, more interestingly genes that showed altered activa-
tion in the Gch1ﬂ/ﬂTie2cre macrophages have not previously been
associated with iNOS or nitric oxide biology, suggesting that changes
in iNOS-mediated redox signaling, rather than only NO, have
important biological effects. Expression of As3MT (arsenic(III)-
methyltransferase) was signiﬁcantly different in BH4-deﬁcient
macrophages at all time points in the gene array analysis, irrespective
of LPS and IFNγ stimulation, indicating that the alteration in expres-
sion is independent of iNOS, but dependent on BH4 and Gch1. As3MT
mediates arsenic methylation and is involved in the endogenous
arsenic detoxiﬁcation process, with As3MT / mice showing slower
excretion of arsenic with enhanced symptoms of arsenic toxicity [37].
While this gene has not been previously reported to be altered by
ROS or RNS, it is perhaps telling that expression of this protein is
associated with alteration in the redox status of cells, with its activity
being increased by glutathione [38]. These data implicate a potential
general role for BH4 in arsenic metabolism, which warrants inves-
tigation of this process in more relevant cell types. The function of
As3MT in the macrophages studied here, in the absence of arsenic, is
unclear. Other genes altered in the Gch1ﬂ/ﬂTie2cre cells have potent
roles in cellular function; Cxcl5 encodes a chemokine that can recruit
both neutrophils and monocytes [39]. Dnmt3l protein is a member of
the de novo DNA methyltransferases, indicating the possibility of
further downstream epigenetic alterations in BH4-deﬁcient cells [40].
Endr2 (Endothelin receptor 2) and Angptl2 (Angiopoietin-like protein
2) have both been highlighted to play roles in vascular inﬂammation
and Panx1 (Pannexin 1) has been linked to the 5-lipoxygenase
pathways in murine macrophages [41–43].
In summary, we describe for the ﬁrst time that deﬁciency of
BH4 in macrophages, as a result of targeted Gch1 deletion, pre-
vents nitric oxide formation by iNOS, but maintains or increases
ROS production, allowing for the ﬁrst time a comparison of NO vs
ROS-mediated effects of iNOS in macrophage inﬂammatory signal-
ing. Multiple effects of Gch1 deletion on cellular ROS levels are
seen both in the presence and in the absence of iNOS expression.
These changes in macrophage redox state are not sufﬁcient to
cause widespread changes in the macrophage inﬂammatory state
or cellular migration. However loss of iNOS-mediated NO produc-
tion leads to speciﬁc alterations in the expression of NRF2 target
genes in the absence of BH4, along with further BH4-dependent
iNOS-independent changes in gene expression. Identiﬁcation of
BH4-mediated NO vs ROS effects in macrophage inﬂammatory
responses highlights new complexity in iNOS biology that has not
been hitherto addressed by models of iNOS deletion, and have
important implications for understanding the role of iNOS, NO,
and BH4 in inﬂammation, immunity, and host defense.
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